title: [Fake malaria drugs].
abstract: The literature on fake medicaments is sparse, even if approximately 15% of all medicaments are fake, a figure that for antimalarials in particular reaches 50% in parts of Africa and Asia. Sub-standard and fake medicines deplete the public's confidence in health systems, health professionals and in the pharmaceutical industry - and increase the risk that resistance develops. For a traveller coming from a rich Western country, choosing to buy e.g. preventive antimalarials over the internet or in poor malaria-endemic areas, the consequences may be fatal. International trade-, control- and police-collaboration is needed to manage the problem, as is the fight against poverty and poor governance.
authors.affiliation: Københavns Universitit, Institut for International Sundhed, Immunologi og Mikrobiologi, Center for Sundhed og Samfund, DK-1410 København K. IBY@sund.ku.dk
authors.forename: Ib Christian
authors.initials: IC
authors.lastname: Bygbjerg
mesh_terms: D000962:Antimalarials / Q000191:economics / Q000600:supply & distribution; D003132:Commerce; D016527:Drug Costs; D004345:Drug Industry / Q000331:legislation & jurisprudence; D005607:Fraud / Q000331:legislation & jurisprudence / Q000517:prevention & control; D014943:Global Health; D006801:Humans; D020407:Internet; D011203:Poverty
chemical_list: D000962:Antimalarials